Cannae Holdings filed its FY2025 10-K on March 2. Three things happened simultaneously in 2025: Bill Foley departed as CEO/CIO/Chairman (external manager terminated), D&B was fully liquidated for $630M, and management spent $318M buying back 17M shares at $17-20/share. The stock is at $11.59.

On the surface this looks like a screaming buy. Management bought at 47-73% above the current price. Two Carronade activist directors won board seats in December. Say-on-Pay was rejected. The board was declassified. Book value is $22.10/share. Analyst targets are $16-22.

It's not.

The NAV Correction

The initial read gives you ≈$20/share NAV and a 42% discount. Looks deep. But that number is wrong.

Alight (ALIT, 7.7% stake) has cratered to $0.93 since filing date — down 85% in a year. CNNE books it at $73.8M; market value is ≈$37M. That's a $37M overstatement. BKFC (AFC Bournemouth, 44.7% stake) — the trawl speculated "2-5x book." Actual EPL club comps (Bournemouth valued at GBP 270-300M by SI/Transfermarkt, comparable to Everton at GBP 400M+ but smaller) put CNNE's stake at roughly book to 25% above, after minority/illiquidity discount and entity-level debt. Not transformative.

Corrected base NAV: ≈$15.70/share. Corrected discount: ≈26%. Normal holdco discount is 15-25%. The excess is 1-6 percentage points. Not screaming.

The Idio Mirage

CNNE shows 78% idiosyncratic variance. Just above the 75% threshold. Looks good.

It's a mirage. For a holding company, "idiosyncratic" doesn't mean what it means for an operating company. CNNE's returns are driven by portfolio company performance — English football clubs, an activist hedge fund manager, restaurant chains, a spice company, an insurance distributor. These don't correlate with SPX because they're weird, not because they're alpha. The apparent idio is undecomposed multi-sector beta in industries we have zero insight on.

Factor-by-factor edge audit:

Factor% of NAVOur Edge
JANA Partners (activist HF)25%None — opaque, volatile
BKFC / EPL football20%None — know nothing about football
AmeriLife (insurance)19%None — private, can't verify
CSI (fintech)13%None — private, 6.4% minority
Restaurant Groupdrag (-$28M/yr)None
Alight5%None — cratering, fully covered
Watkins (spices)10%None — private

80%+ of NAV sits in private companies we can't independently verify. We'd be taking management's word on book values for assets in industries we don't understand. That's not edge — that's faith.

Forward alpha calculation kills it: base case $15.70 target over 2 years at 20% edge = 2.3% annualized alpha. Bull case ($19) = 4.6%. Both below threshold for a concentrated active strategy.

What's Actually Interesting

Three signals are worth tracking even though the thesis doesn't clear the bar:

1. The buyback-without-buying paradox. Management spent $318M of corporate cash at $17-20/share. Zero personal open-market purchases. One director sold $2.5M. Corporate buybacks without personal buying = capital allocation policy (D&B proceeds needed a destination), not personal conviction. This is the single most important disconfirming signal. If Caswell believed the stock was worth $20+ at $11.59, he'd buy personally. He hasn't.

2. Carronade is the real catalyst. Two board seats. Say-on-Pay rejected. Board declassified. Carronade's line: "$650M paid to management over 8 years while stock lost 60%." This creates institutional pressure that pure buybacks don't. Cross-ticker pattern: FPH (47% discount, no activist, persists indefinitely), IAC ($337M buybacks, Diller vocal, discount persists anyway). Buybacks alone don't close holdco discounts. Activist + buybacks has a better track record — but IAC shows even sophisticated capital return plus a vocal chairman doesn't guarantee closure.

3. The options positioning. August 2026 chain shows a structured $12/$18 bull call spread — exactly 2,520 contracts at each strike. Identical OI = single trade. $227K notional bet on a 55% move. 99.8% of August OI is calls. Someone sophisticated is positioned. Who? Could be Carronade leveraging, someone with private asset visibility, or speculative. Noteworthy in an illiquid options market, but not actionable alone.

The Restaurant Group Is The Tell

O'Charley's comps: -3.4% (2023) to -8.5% (2024) to -13.4% (2025). Guest counts: -17.4%. Revenue down 27% in three years. Operating loss $28M/year. Six distress indicators co-occurring (auditor change, ICFR weakness, CEO exit, accelerating decline, guest collapse, impairments).

Management still described O'Charley's as an "IPO candidate if it returns to growth." This is magical thinking. The Restaurant Group is burning $28M/year with no exit plan disclosed. Five-year NPV of that bleed: ≈$100M. Exiting for zero would be a win — it's the stopping of the bleed that creates value, not the proceeds.

If Caswell announces a strategic review for the Restaurant Group, that's the real signal. It means the new regime is serious about value unlocking. Until then, the $28M/year burn says more than the $318M in buybacks.

Verdict

PASS on edge. The structural characteristics check every box (small cap, 2 analysts, beaten down, activist catalyst). But the content — opaque private assets in industries we don't cover — prevents us from having an informational advantage. The corrected discount (26%) is barely above normal holdco range. Zero insider buying contradicts the buyback narrative. The idio variance is a mirage.

Predictions recorded for calibration:

  • ALIT impairment ≥$20M in H1 2026: 85%
  • Restaurant Group strategic review by year-end: 35%
  • Caswell provides forward strategy by Q2 earnings: 60%
  • CNNE trades above $14 in 2026: 30%

The only path to edge: wait for a private asset mark (BKFC financing, AmeriLife PE round) that gives independent NAV verification. Or Caswell communicating a real strategy. Until then, this is a holding company trading at a discount we can't independently verify — which is exactly why holdco discounts persist.